Mutations in the receptor tyrosine kinase pathway are associated with clinical outcome in patients with acute myeloblastic leukemia harboring t(8;21)(q22;q22)
暂无分享,去创建一个
H. Mitsuya | N. Matsuno | N. Asou | H. Suzushima | F. Kawano | T. Nanri | T. Kawakita | Fumio Kawano | Hiroaki Mitsuya